Express News | Lantern Pharma Announces First Patient Dosed in Japan for the Expansion Cohort in the Phase 2 Harmonic™ Clinical Trial of LP-300 in Never-Smoker Nsclc Patients

BreakingsNov 19 21:00

Lantern Pharma Inc. (LTRN) Q3 2024 Earnings Call Transcript

Earnings Call TranscriptsNov 9 08:23

Lantern Pharma Advances AI-Driven Cancer Therapies

TipRanksNov 8 12:48

Lantern Pharma 3Q Loss/Shr 42c >LTRN

Dow JonesNov 8 06:37

Lantern Pharma | 10-Q: Q3 2024 Earnings Report

SECNov 8 05:14 · Announcements

Express News | Lantern Pharma Q3 Net Income USD -4.5 Million

BreakingsNov 8 05:05